Scottish Fish Immunology Research Centre, School of Biological Sciences, University of Aberdeen, Tillydrone Avenue, Aberdeen, AB24 2TZ, UK.
Elanco Canada Ltd, Aquaculture Research and Development, P.O. Box 17, Victoria PE, C0A 2G0, Canada.
Fish Shellfish Immunol. 2021 Jul;114:171-183. doi: 10.1016/j.fsi.2021.04.024. Epub 2021 Apr 30.
Adjuvants are the helper substances that increase vaccine efficacy by enhancing the potency and longevity of specific immune responses to antigens. Most existing fish vaccines are presented in the form of oil-based emulsions delivered by intraperitoneal injection. The characterization of their mode of action is a valuable aid to future vaccine development, particularly for the potential identification and stimulation of specific immunological pathways related to the desired protective response. This study characterized the expression of selected immune-related genes in the peritoneal cavity, head kidney and spleen following the administration of two adjuvanted-bacterial vaccines thought to induce humoral (Montanide™ ISA 763A VG) or humoral and cell mediated (Montanide™ ISA 761 VG) immune responses, to determine if differences in responsiveness are readily apparent. The most informative site was the spleen, where Montanide™ ISA 763A VG + bacterin gave rise to upregulation of genes driving T-cell/lymphoid responses, namely IL-2, IL-15 and IL-21. This combined with upregulation of IFNγ1 and IFNγ2, IL-4/13B2, p35A1 and p40 (B1 and C) indicated that the induction of Th1 and possibly Th2 immunity was occurring in fish vaccinated with this adjuvant. Perhaps the most intriguing finding was the lack of a detectable Th1 response in fish given Montanide™ ISA 761 VG + bacterin, suggesting some other arm of the immune system is activated to give protection. Whatever the reason for the different responses detected, it is clear from the present study that the adjuvant used has a major impact on the responses elicited. Since these differences are readily detectable it allows, in principle, their use to help select the most appropriate adjuvants for inclusion into fish vaccines, where the type of response elicited may need to be tailored to a particular pathogen to confer protection.
佐剂是通过增强对抗原的特定免疫反应的效力和持久性来提高疫苗功效的辅助物质。大多数现有的鱼类疫苗都以油基乳液的形式通过腹腔内注射呈现。它们作用模式的特征是对未来疫苗开发的宝贵帮助,特别是对于潜在的鉴定和刺激与所需保护反应相关的特定免疫途径。本研究在腹腔内、头部肾脏和脾脏中描述了两种佐剂细菌疫苗(被认为诱导体液(Montanide™ISA763AVG)或体液和细胞介导(Montanide™ISA761VG)免疫反应)给药后选定的免疫相关基因的表达,以确定是否容易明显看出反应的差异。最具信息量的部位是脾脏,其中 Montanide™ISA763AVG+菌苗引起驱动 T 细胞/淋巴细胞反应的基因的上调,即 IL-2、IL-15 和 IL-21。这与 IFNγ1 和 IFNγ2、IL-4/13B2、p35A1 和 p40(B1 和 C)的上调相结合表明,用这种佐剂接种的鱼类中发生了 Th1 和可能的 Th2 免疫诱导。也许最有趣的发现是,给予 Montanide™ISA761VG+菌苗的鱼类中未检测到可检测的 Th1 反应,这表明免疫系统的其他分支被激活以提供保护。无论检测到不同反应的原因是什么,从本研究清楚地看出,所使用的佐剂对引起的反应有重大影响。由于这些差异很容易被检测到,因此原则上可以使用它们来帮助选择最适合鱼类疫苗的佐剂,其中引起的反应类型可能需要根据特定病原体进行调整以提供保护。